SEC EDGAR · Insider purchase
RAPP: Young Wendy B. reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow RAPP- Became public
- Oct 22, 2026
- Event / period date
- Oct 22, 2026
- Collected
- Nov 8, 2026, 7:56 PM EST
Why this is connected
This filing identifies Rapport Therapeutics, Inc. as the issuer of the security. The company's SEC identifier connects it to RAPP.
Reported transactions
Young Wendy B. (Director)
3,789 shares · Common Stock
Oct 22, 2026 · $26.39 per share
Value calculated from the reported shares and prices: $99,991.71.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-10-22</periodOfReport>
<issuer>
<issuerCik>0002012593</issuerCik>
<issuerName>Rapport Therapeutics, Inc.</issuerName>
<issuerTradingSymbol>RAPP</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0002042847</rptOwnerCik>
<rptOwnerName>Young Wendy B.</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>RAPPORT THERAPEUTICS, INC.</rptOwnerStreet1>
<rptOwnerStreet2>99 HIGH STREET, SUITE 2100</rptOwnerStreet2>
<rptOwnerCity>BOSTON</rptOwnerCity>
<rptOwnerState>MA</rptOwnerState>
<rptOwnerZipCode>02110</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>true</isDirector>
<isOfficer>false</isOfficer>
<isTenPercentOwner>false</isTenPercentOwner>
<isOther>false</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>false</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<transactionDate>
<value>2026-10-22</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>false</equitySwapInvolved>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value>3789</value>
</transactionShares>
<transactionPricePerShare>
<value>26.39</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>13289</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<ownerSignature>
<signatureName>/s/ Troy Ignelzi, Attorney-in-Fact</signatureName>
<signatureDate>2026-10-22</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.